Denmark
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 148.22 M
|
Dec. 31, 2023 | USD 130.66 | 2.64% |
|
Denmark |
|
2 |
USD 134.26 M
|
Dec. 31, 2023 | USD 96.67 | -5.32% |
|
Denmark |
|
3 |
USD 2.71 M
|
Dec. 31, 2023 | USD 1.58 | -5.64% |
|
Denmark |
|
4 |
USD -4.59 M
|
Dec. 31, 2023 | USD 21.56 | -4.59% |
|
Denmark |
|
5 |
USD -308.62 M
|
Dec. 31, 2023 | USD 6.01 | -1.79% |
|
Denmark |
|
6 |
USD -361.32 M
|
Dec. 31, 2023 | USD 38.45 | -4.49% |
|
Denmark |
The Drugstores & Retail Pharmacies company in Denmark with the highest Net Cash Used Provided By Financing Activities is Ascendis Pharma A/S (NasdaqGS: ASND) at USD 148.22 M.
The Drugstores & Retail Pharmacies company in Denmark with the lowest Net Cash Used Provided By Financing Activities is Demant A/S (Copenhagen Stock Exchange: DEMANT.CO) at USD -361.32 M.
The top 10 Drugstores & Retail Pharmacies companies in Denmark by Net Cash Used Provided By Financing Activities are Ascendis Pharma A/S, Zealand Pharma A/S, ViroGates A/S, ALK-Abelló A/S, H. Lundbeck A/S and Demant A/S.
The bottom 10 Drugstores & Retail Pharmacies companies in Denmark by Net Cash Used Provided By Financing Activities are Demant A/S, H. Lundbeck A/S, ALK-Abelló A/S, ViroGates A/S, Zealand Pharma A/S and Ascendis Pharma A/S.